The first batch of Johnson & Johnson coronavirus vaccines was temporarily sealed after arriving in Denmark.
On April 14th, local time, Danish Radio and Television (DR) reported that Johnson & Johnson’s first batch of coronavirus vaccines were temporarily sealed in the freezer after arriving at the Danish Serum Research Institute.
Last week, Johnson & Johnson’s coronavirus vaccine suffered several serious side effects after vaccination. U.S. health authorities suspended the vaccination of Johnson & Johnson vaccine, and the vaccine is now facing the same situation in Europe.
It is reported that Denmark will wait for further information before deciding whether to use the vaccine.
The first Johnson & Johnson coronavirus vaccines that arrived in Iceland were temporarily sealed.
On April 15th local time, Icelandic National Radio and Television (RUV) reported that the first batch of Johnson & Johnson coronavirus vaccine arrived in Iceland on the morning of the 14th, with a total of 2,400 doses. The Icelandic authorities have now stored them until they are decided to use them.
Sweden waits for notice from the European Drug Administration before deciding whether to use Johnson & Johnson coronavirus vaccine.
On April 14th, local time, Swedish television (SVT) reported that investigators of the Swedish Public Health Agency said that 31,000 doses of Johnson & Johnson coronavirus vaccine had arrived in Sweden, but they would not be distributed for use. The Swedish Public Health Agency is awaiting an evaluation from the European Drug Administration (EMA).
According to the data of the Swedish Public Health Agency, there were 8,879 new confirmed cases of COVID-19 in the country on the 14th, with a total of 885,385 confirmed cases nationwide, 60 new deaths and 13,720 deaths.
A total of 1543,414 people in Sweden were vaccinated with one dose of the coronavirus vaccine, accounting for 18.8% of the adult population; 63,1807 people were vaccinated with two doses, or 7.7% of the adult population.